Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) — Cash Flow-to-Debt Ratio
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) has a Cash Flow-to-Debt Ratio of 0.16x as of September 2025, meaning its operating cash flow of CN¥109.83 Million could theoretically repay 0% of its total liabilities (CN¥676.78 Million) in one year. See Shanghai Shenqi Pharmaceutical Investmen free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A across 28 annual periods. Also explore 600613 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (1998–2025)
Year-by-year debt coverage analysis for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A. For market capitalisation and broader financial context, see Shanghai Shenqi Pharmaceutical Investmen market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.17x | CN¥124.47 Million | CN¥747.59 Million | ▼ -44.8% |
| 2024 | 0.30x | CN¥207.79 Million | CN¥689.01 Million | ▲ +24.3% |
| 2023 | 0.24x | CN¥215.59 Million | CN¥888.77 Million | ▼ -23.4% |
| 2022 | 0.32x | CN¥319.23 Million | CN¥1.01 Billion | ▲ +30.0% |
| 2021 | 0.24x | CN¥184.26 Million | CN¥756.45 Million | ▲ +89.3% |
| 2020 | 0.13x | CN¥99.10 Million | CN¥770.28 Million | ▼ -10.3% |
| 2019 | 0.14x | CN¥128.28 Million | CN¥894.60 Million | ▼ -49.0% |
| 2018 | 0.28x | CN¥148.53 Million | CN¥527.74 Million | ▲ +137.5% |
| 2017 | 0.12x | CN¥66.99 Million | CN¥565.34 Million | ▲ +11689.9% |
| 2016 | 0.00x | CN¥570.41K | CN¥567.56 Million | ▼ -98.7% |
| 2015 | 0.08x | CN¥30.12 Million | CN¥384.98 Million | ▲ +332.0% |
| 2014 | -0.03x | CN¥-8.62 Million | CN¥255.60 Million | ▼ -108.3% |
| 2013 | 0.41x | CN¥74.75 Million | CN¥183.42 Million | ▲ +188.6% |
| 2012 | -0.46x | CN¥-11.18 Million | CN¥24.31 Million | ▼ -336.3% |
| 2011 | -0.11x | CN¥-3.33 Million | CN¥31.57 Million | ▼ -109.1% |
| 2010 | 1.16x | CN¥33.04 Million | CN¥28.48 Million | ▲ +814.1% |
| 2009 | 0.13x | CN¥7.69 Million | CN¥60.61 Million | ▼ -73.4% |
| 2008 | 0.48x | CN¥25.26 Million | CN¥53.04 Million | ▲ +168.5% |
| 2007 | 0.18x | CN¥16.01 Million | CN¥90.23 Million | ▲ +408.6% |
| 2006 | -0.06x | CN¥-6.05 Million | CN¥105.19 Million | ▼ -119.3% |
| 2005 | 0.30x | CN¥32.72 Million | CN¥109.67 Million | ▲ +1012.5% |
| 2004 | 0.03x | CN¥4.96 Million | CN¥184.98 Million | ▼ -16.9% |
| 2003 | 0.03x | CN¥4.52 Million | CN¥139.96 Million | ▼ -71.1% |
| 2002 | 0.11x | CN¥16.02 Million | CN¥143.38 Million | ▲ +185.6% |
| 2001 | -0.13x | CN¥-20.51 Million | CN¥157.14 Million | ▼ -182.1% |
| 2000 | 0.16x | CN¥26.85 Million | CN¥168.97 Million | ▲ +824.8% |
| 1999 | -0.02x | CN¥-3.28 Million | CN¥149.46 Million | ▼ -111.6% |
| 1998 | 0.19x | CN¥72.67 Million | CN¥384.28 Million | — |